Kobo Biotech Ltd. - Research Center
531541 KOBO Group (Z) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
23.83 |
23.83 |
23.83 |
23.83 |
23.83 |
Share application money
Preference share capital
Reserves & surplus
-151.81 |
-146.25 |
-131.03 |
-111.80 |
-90.79 |
Secured loans
139.84 |
140.72 |
208.26 |
198.86 |
184.46 |
Unsecured loans
Total
11.86 |
18.29 |
101.06 |
110.89 |
117.50 |
Gross block
103.68 |
103.68 |
192.42 |
192.42 |
192.42 |
Less : revaluation reserve
Less : accumulated depreciation
66.09 |
62.02 |
135.51 |
129.88 |
124.00 |
Net block
37.59 |
41.66 |
56.91 |
62.54 |
68.42 |
Capital work-in-progress
Investments
Current assets, loans & advances
37.74 |
37.53 |
159.24 |
159.35 |
156.58 |
Less : current liabilities & provisions
63.47 |
60.90 |
129.53 |
125.44 |
121.95 |
Total net current assets
-25.73 |
-23.37 |
29.71 |
33.90 |
34.63 |
Miscellaneous expenses not written
Total
11.86 |
18.29 |
101.06 |
110.89 |
117.50 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
238.25 |
238.25 |
238.25 |
238.25 |
238.25 |